FDA panel promotes misinformation about antidepressants during pregnancy


  • Now playing

    The FDA panel promotes erroneous information about antidepressants during pregnancy

    03:05

  • Next

    Bipartisan push aims to make delivery free amid the growing costs

    02:49

  • Mom wins ultramarathon, breastfeeding along the way

    02:30

  • Velshi: Trump wants women to have more babies, but do not help once babies are born

    05:37

  • The FDA approves the first test at home for cervical cancer

    02:08

  • Cold water tires may not accelerate the recovery after women’s training, the study suggests

    03:55

  • States promote legislation related to menopause as consciousness grows

    04:41

  • How abortion laws affect women who experience spontaneous abortions

    04:07

  • The artist draws portraits that honor the black women who died during childbirth

    04:04

  • ‘Not designed to protect ours

    04:15

  • Cancer caused by HPV is increasing in some women in the United States

    03:23

  • Hundreds of demands allege FIV errors in fertility clinics throughout the country

    05:25

  • More older women become mothers for the first time when young pregnancies fall

    04:02

  • Texas millenary monks share their perimenopause trip

    02:49

  • Recently dismissed pregnant federal employees face the loss of insurance

    02:50

  • The loss of late pregnancy is more common in the south, says the report

    04:42

  • Trump announces an executive order on IVF treatments

    02:01

  • The “hostile and toxic atmosphere” in the anti -abortion states is a threat to medical care, and doctors

    08:38

  • Naomi Watts talks about menopause, new book ‘Dare i say it’

    05:16

  • Abortions rise unexpectedly after the revocation of Roe v. Wade

    02:54

News News now

The NBC News medical collaborator, Dr. Natalie Azar, reports on the FDA discussion panel on the use of antidepressants during pregnancy. The panel shared erroneous information and made of context, according to several psychiatrists who tuned the meeting. Medical professionals say that the risk of unreasonable depression far exceeds the potential risks of the medicine for the mother and the child.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *